These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 12505426)
1. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426 [TBL] [Abstract][Full Text] [Related]
2. Activation of caspase-8 in the Alzheimer's disease brain. Rohn TT; Head E; Nesse WH; Cotman CW; Cribbs DH Neurobiol Dis; 2001 Dec; 8(6):1006-16. PubMed ID: 11741396 [TBL] [Abstract][Full Text] [Related]
3. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Rohn TT; Head E; Su JH; Anderson AJ; Bahr BA; Cotman CW; Cribbs DH Am J Pathol; 2001 Jan; 158(1):189-98. PubMed ID: 11141492 [TBL] [Abstract][Full Text] [Related]
4. Activation of caspase-6 in aging and mild cognitive impairment. Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160 [TBL] [Abstract][Full Text] [Related]
5. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226 [TBL] [Abstract][Full Text] [Related]
6. Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain. Day RJ; Mason MJ; Thomas C; Poon WW; Rohn TT PLoS One; 2015; 10(7):e0132637. PubMed ID: 26161867 [TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid deposition and neurofibrillary tangle association with caspase activation in Down syndrome. Head E; Lott IT; Cribbs DH; Cotman CW; Rohn TT Neurosci Lett; 2002 Sep; 330(1):99-103. PubMed ID: 12213643 [TBL] [Abstract][Full Text] [Related]
8. Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease. Zhao M; Su J; Head E; Cotman CW Neurobiol Dis; 2003 Dec; 14(3):391-403. PubMed ID: 14678756 [TBL] [Abstract][Full Text] [Related]
9. The role of caspase cleavage of tau in Alzheimer disease neuropathology. Cotman CW; Poon WW; Rissman RA; Blurton-Jones M J Neuropathol Exp Neurol; 2005 Feb; 64(2):104-12. PubMed ID: 15751224 [TBL] [Abstract][Full Text] [Related]
10. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Gamblin TC; Chen F; Zambrano A; Abraha A; Lagalwar S; Guillozet AL; Lu M; Fu Y; Garcia-Sierra F; LaPointe N; Miller R; Berry RW; Binder LI; Cryns VL Proc Natl Acad Sci U S A; 2003 Aug; 100(17):10032-7. PubMed ID: 12888622 [TBL] [Abstract][Full Text] [Related]
11. Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo. Guillozet-Bongaarts AL; Cahill ME; Cryns VL; Reynolds MR; Berry RW; Binder LI J Neurochem; 2006 May; 97(4):1005-14. PubMed ID: 16606369 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease. Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308 [TBL] [Abstract][Full Text] [Related]
13. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. Selznick LA; Holtzman DM; Han BH; Gökden M; Srinivasan AN; Johnson EM; Roth KA J Neuropathol Exp Neurol; 1999 Sep; 58(9):1020-6. PubMed ID: 10499444 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease. Ferrer I Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160 [TBL] [Abstract][Full Text] [Related]
15. Both N-terminal and C-terminal fragments of presenilin 1 colocalize with neurofibrillary tangles in neurons and dystrophic neurites of senile plaques in Alzheimer's disease. Chui DH; Shirotani K; Tanahashi H; Akiyama H; Ozawa K; Kunishita T; Takahashi K; Makifuchi T; Tabira T J Neurosci Res; 1998 Jul; 53(1):99-106. PubMed ID: 9670996 [TBL] [Abstract][Full Text] [Related]
16. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease. Rohn TT Brain Res; 2008 Sep; 1228():189-98. PubMed ID: 18634762 [TBL] [Abstract][Full Text] [Related]
17. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Su JH; Zhao M; Anderson AJ; Srinivasan A; Cotman CW Brain Res; 2001 Apr; 898(2):350-7. PubMed ID: 11306022 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I; Blanco R; Carmona M; Puig B J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404 [TBL] [Abstract][Full Text] [Related]
19. Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain. Mouser PE; Head E; Ha KH; Rohn TT Am J Pathol; 2006 Mar; 168(3):936-46. PubMed ID: 16507909 [TBL] [Abstract][Full Text] [Related]
20. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation. Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]